USA: A recent study, published in JAMA Network Open as a research letter, highlights a significant link between anti-obesity ...

Researchers at Henry Ford Health, collaborating with WeightWatchers International, report that more than 40% of individuals ...

A collection of common and new medications is showing good results against the constellation of symptoms that individualize ...

Nearly half of individuals consuming alcohol at baseline reduced their alcohol consumption following the initiation of AOMs.

University of Wisconsin–Madison biochemists have developed a new, efficient method that may give first responders, ...

A study using Swedish patient data found anti-obesity drugs were linked with fewer hospitalizations related to alcohol use, ...

A study of 14,000 WeightWatchers participants is the latest to suggest that Ozempic and similar obesity drugs could be ...

University of Wisconsin–Madison biochemists have developed a new, efficient method that may give first responders, ...

After years of struggling with alcohol dependence, Shana found a combination of treatment and counseling that works for her.

Nearly half of participants in a weight-loss program who consumed alcohol at baseline began drinking less after adding an ...

Findings suggest semaglutide and other GLP-1 agonists may significantly reduce alcohol use disorder hospitalizations, ...

This cohort study among individuals participating in a weight loss program found that nearly half of those consuming alcohol at baseline decreased their alcohol use after anti-obesity medication ...